- Report
- August 2023
- 81 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- August 2021
- 131 Pages
Global
From €3200EUR$3,557USD£2,849GBP
- Report
- June 2021
- 89 Pages
Global
From €3200EUR$3,557USD£2,849GBP
- Report
- February 2024
- 110 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- February 2024
- 88 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- October 2023
- 85 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- August 2023
- 103 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- July 2023
- 114 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- July 2023
- 106 Pages
Global
From €3500EUR$3,891USD£3,116GBP
- Report
- October 2018
- 9 Pages
United States
From €577EUR$599USD£496GBP
- Report
- September 2022
- 80 Pages
Africa
From €3657EUR$3,795USD£3,146GBP
- Report
- October 2019
- 175 Pages
Global
From €1397EUR$1,450USD£1,202GBP
- Report
- July 2019
- 175 Pages
Global
From €1397EUR$1,450USD£1,202GBP
- Book
- March 2020
- 281 Pages
- Newsletter
- May 2024
Global
From €1010EUR$1,123USD£899GBP
Diabetes is a chronic metabolic disorder that affects the body's ability to produce or respond to insulin, a hormone that regulates blood sugar levels. Endocrinology is the medical specialty that focuses on the diagnosis and treatment of diseases related to hormones and the endocrine system. Diabetes is one of the most common endocrine disorders, and the market for diabetes treatments is a major part of the endocrinology market.
Diabetes treatments include lifestyle modifications, such as diet and exercise, as well as medications and insulin therapy. In addition, diabetes management often includes regular monitoring of blood sugar levels, as well as education and support for patients.
The diabetes market includes a variety of companies that develop and market treatments for diabetes, such as insulin, glucose monitors, and other medications. Companies in the diabetes market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. Show Less Read more